Specific aim 1: Develop in vitro 3D brain organoid models derived from human adult peripheral CD34+ cells to study neural development and degeneration. Interactions with non-neuronal cells plays an important role in neural development and neurological disorders. We have established protocols to produce brain organoids with endothelial cells. We used RNA-seq data to study the genes expressed in the organoids and their relevance in studying neural developmental disorders. In collaboration with Dr. Kousa from CNHS, who have generated gene sets containing 7972 genes that associated with 52 neural development and degenerative disorders. we found 7673 (96%) genes were expressed in the 3D organoids, suggesting they can be used as model for studying these disorders. A proposal has been submitted to use this model to study the genes associated with ZIKA infection-induced defect in brain development. We also took advantage of recently published protocols that enabled microglial differentiation to make microglia incorporated brain organoids. By incorporating iPSC-derived CD34+ blood progenitor cells into the 3D organoids, following neuronal differentiation, we observed that microglia were generated within the organoids, which numbers were further increased by microglial-inducing cytokines. This model when optimized, will be useful to study microglial associated neurodegenerative disorders such as Parkinsons disease.
Specific aim 2 : Study the role of HERV-K on human neural development. We have found that human endogenous retroviruses K (HERV-K) is expressed on human iPSC. Inhibition of HERV-K Env protein enhanced neuronal differentiation through inhibiting mTOR pathway and LPCAT1 activation. It was reported that mTOR activation may be a main factor differentiating human and other primate brain developments. To see if HERV-K play a role in human brain evolution, we generated neural progenitor cells from fibroblasts of Rhesus monkey, which contains no HERV-K. By transfecting the rhesus neural cells with plasmid containing HERV-K envelope, we observed that incorporation of HERV-K envelope in the rhesus neuronal cells dramatically increased expression of rps6, a key effector of mTOR pathway, and LPCAT1, while impaired the spontaneous neuronal differentiation. Our results indicate that HERV-K incorporation may have played a role in the human brain evolution.
Specific aim 3 : Study the role of association of HERV-K and ALS. It has been implied that retro elements including HERV-K in human genome may be associated with motor neuron disorder ALS, especially in a subset of ALS with C9orf72 mutations. To confirm such relations and study the possible mechanism between HERV-K expression and ALS, we generated motor neuron lines from five PBMC samples from ALS patients with C9orf72 mutations. Preliminary result showed an increased expression of HERV-K in ALS motor neurons compared to cells generated from health donors. We will use this in vitro model to delineate the mechanism.
Specific aim 4 : facilitate the research and therapeutic developments for neurological disorders using our models and methods. We are in collaboration with other investigators by providing material support and training of the iNSC/iPSC generation. We are helping Dr. Henry Levis lab with technique support, cell lines and expertise on developing a project studying the retroelements in neurological disorders using neural stem cells. The project has resulted in decent result that showed certain retroelement may regulate adjacent gene expression and participate in neurological disorders. A manuscript based on the collaboration is in preparation. The collaboration with Dr. Katherine Roche and Dr. Sergey Iordanskiy also resulted in additional manuscripts.

Project Start
Project End
Budget Start
Budget End
Support Year
8
Fiscal Year
2019
Total Cost
Indirect Cost
City
State
Country
Zip Code
Lee, Paul R; Johnson, Tory P; Gnanapavan, Sharmilee et al. (2017) Protease-activated receptor-1 activation by granzyme B causes neurotoxicity that is augmented by interleukin-1?. J Neuroinflammation 14:131
Hu, Lina; Wang, Tongguang; Gocke, Anne R et al. (2013) Blockade of Kv1.3 potassium channels inhibits differentiation and granzyme B secretion of human CD8+ T effector memory lymphocytes. PLoS One 8:e54267
Bachani, M; Sacktor, N; McArthur, J C et al. (2013) Detection of anti-tat antibodies in CSF of individuals with HIV-associated neurocognitive disorders. J Neurovirol :
Shukla, Varsha; Zheng, Ya-Li; Mishra, Santosh K et al. (2013) A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer's disease phenotypes in model mice. FASEB J 27:174-86
Uzasci, Lerna; Nath, Avindra; Cotter, Robert (2013) Oxidative stress and the HIV-infected brain proteome. J Neuroimmune Pharmacol 8:1167-80
Morgan, Richard A; Chinnasamy, Nachimuthu; Abate-Daga, Daniel et al. (2013) Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy. J Immunother 36:133-51
Uzasci, Lerna; Nath, Avindra (2013) Robert J. Cotter (1943-2012): From Mass Spectrometer Development to the Exploration of Life. J Neuroimmune Pharmacol :
Wang, Tongguang; Lee, Myoung-Hwa; Choi, Elliot et al. (2012) Granzyme B-induced neurotoxicity is mediated via activation of PAR-1 receptor and Kv1.3 channel. PLoS One 7:e43950
Nath, Samir; Bachani, Muznabanu; Harshavardhana, Deepti et al. (2012) Catechins protect neurons against mitochondrial toxins and HIV proteins via activation of the BDNF pathway. J Neurovirol 18:445-55
Rumbaugh, Jeffrey A; Bachani, Muznabanu; Li, Wenxue et al. (2012) HIV immune complexes prevent excitotoxicity by interaction with NMDA receptors. Neurobiol Dis 49C:169-176

Showing the most recent 10 out of 15 publications